KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Gains from Investment Securities (2016 - 2026)

Pfizer has reported Gains from Investment Securities over the past 18 years, most recently at -$22.0 million for Q1 2026.

  • Quarterly Gains from Investment Securities fell 114.47% to -$22.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Mar 2026, up 2366.67% year-over-year, with the annual reading at $4.7 billion for FY2025, 1556.54% up from the prior year.
  • Gains from Investment Securities was -$22.0 million for Q1 2026 at Pfizer, down from $5.0 billion in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $5.0 billion in Q4 2025 and troughed at -$2.3 billion in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $13.0 million (2024), against an average of $282.7 million.
  • Year-over-year, Gains from Investment Securities plummeted 400.0% in 2022 and then surged 1195.0% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $200.0 million in 2022, then plummeted by 1246.5% to -$2.3 billion in 2023, then soared by 100.57% to $13.0 million in 2024, then surged by 38284.62% to $5.0 billion in 2025, then crashed by 100.44% to -$22.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Gains from Investment Securities are -$22.0 million (Q1 2026), $5.0 billion (Q4 2025), and -$14.0 million (Q3 2025).